- Novo's pill for kids; Altimmune’s $225M offering; Merck teams with Google CloudNovo Nordisk’s GLP-1 pill works in kids with diabetes: Type 2 diabetes patients aged 10 to 17 who took Rybelsus for about six months had a statistically significant 0.83% cut in their blood sugar l…Endpoints · 3mo ago↗ source
- Amneal to buy a biosimilar company; Samsung Bio workers protestPlus, news about Avonik, a supply chain transparency bill and Nucleus RadioPharma: 💰 Amneal Pharmaceuticals to acquire biosimilar maker for $375M upfront: The generics and specialty drugmaker is…Endpoints · 3mo ago↗ source
- Endpoints wins Neal Awards for Trump and gene editing coverage, JPM eventEndpoints News was recognized with three 2026 Neal Awards for its coverage of the drug industry's relationship with the Trump administration, a three-part series on the future of CRISPR gene editin…